K
Kyla A. McKay
Researcher at Karolinska Institutet
Publications - 39
Citations - 1135
Kyla A. McKay is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 17, co-authored 30 publications receiving 784 citations. Previous affiliations of Kyla A. McKay include University of British Columbia & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Lindsay Berrigan,John D. Fisk,Scott B. Patten,Helen Tremlett,Christina Wolfson,Sharon Warren,Kirsten M. Fiest,Kyla A. McKay,Ruth Ann Marrie +8 more
TL;DR: Investigations that reduce disability are expected to yield the most substantial improvement in HRQoL and interventions targeting other factors amenable to change, particularly depression but also anxiety, fatigue, and physical comorbidities, may all result in meaningful improvements in HRZoL.
Journal ArticleDOI
Psychiatric comorbidity is associated with disability progression in multiple sclerosis.
Kyla A. McKay,Helen Tremlett,John D. Fisk,Tingting Zhang,Scott B. Patten,Lorne F. Kastrukoff,Trudy Campbell,Ruth Ann Marrie +7 more
TL;DR: The presence of psychiatric comorbidities, which were common in incident MS cohort, increased the severity of subsequent neurologic disability, and optimization management of psychiatricComorbidity should be explored as a means of potentially mitigating disability progression in MS.
Journal ArticleDOI
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
TL;DR: Exposure to the Epstein‐Barr virus, particularly if this manifested as infectious mononucleosis during adolescence, was associated with increased MS risk and upper respiratory tract infections were most commonly associated with an increase in relapses.
Journal ArticleDOI
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review
TL;DR: A gap in understanding of the risk factors associated with the onset of PPMS is exposed, with current knowledge being predominated by relapsing-onset MS.
Journal ArticleDOI
Cholesterol and markers of cholesterol turnover in multiple sclerosis : Relationship with disease outcomes
TL;DR: The data indicate that cholesterol and markers of cholesterol turnover have potential to be used clinically as biomarkers of disease activity and may even be implicated in the pathogenesis of MS.